Ring sideroblasts and sideroblastic anemias
暂无分享,去创建一个
[1] C. Beaumont,et al. Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia , 2011, Haematologica.
[2] M. Cazzola,et al. Mutation Analysis of TET2 Reveals the Clonal Nature of Refractory Anemia with Ring Sideroblasts , 2010 .
[3] J. Tisdale,et al. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. , 2010, The Journal of clinical investigation.
[4] E. Neufeld,et al. Systematic molecular genetic analysis of congenital sideroblastic anemia: Evidence for genetic heterogeneity and identification of novel mutations , 2010, Pediatric blood & cancer.
[5] M. Cazzola,et al. Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G‐CSF , 2009, British journal of haematology.
[6] M. Cazzola,et al. Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. , 2009, Blood.
[7] M. Fleming,et al. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia , 2009, Nature Genetics.
[8] B. Bain,et al. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts , 2008, Haematologica.
[9] Luca Malcovati,et al. The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts , 2008, PloS one.
[10] A. Iolascon,et al. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. , 2007, Blood.
[11] Li Wang,et al. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. , 2006, Blood.
[12] M. Cazzola,et al. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome , 2006, Leukemia.
[13] Luca Malcovati,et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] B. Paw,et al. Deficiency of glutaredoxin 5 reveals Fe–S clusters are required for vertebrate haem synthesis , 2005, Nature.
[15] M. Cazzola,et al. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes. , 2005, Blood.
[16] M. Cazzola,et al. Flow Cytometry Evaluation of Erythroid Dysplasia in Patients with Myelodysplastic Syndrome. , 2004 .
[17] M. Cazzola,et al. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. , 2003, Blood.
[18] M. Cazzola,et al. Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation. , 2002, Blood.
[19] M. Cazzola,et al. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females. , 2000, Blood.
[20] M. Cazzola,et al. Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis. , 1999, Blood.
[21] D. Bishop,et al. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts. , 1995, The Journal of clinical investigation.
[22] M. Cazzola,et al. Natural history of idiopathic refractory sideroblastic anemia. , 1988, Blood.